Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

309 Press Releases
DateTitleCompany
01 Apr 15 Teva Announces FDA Approval of ProAir® RespiClick Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Mar 15 Teva Expands Hypertension Line with Launch of Generic Exforge® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Mar 15 Teva Announces New Head of Business Development Strategy and Innovation Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Mar 15 Teva’s TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study Demonstrating Treatment Concept After a Single Dose Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Mar 15 Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Mar 15 Teva to Present at the Barclays Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Mar 15 Teva Announces Sale of Sellersville PA Facility Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Feb 15 Teva Announces Early Results of Debt Tender Offer Pricing Election of Early Settlement and Increase in Maximum Amount and Priority 2 Notes Tender Cap Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Feb 15 Teva to Present at the Cowen & Company 35th Annual Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Feb 15 Teva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine Rapid Infusion Product Teva Pharmaceutical Industries Ltd.
10 Feb 15 Teva Files 2014 Annual Report on Form 20-F Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Feb 15 Teva Thanks Dr. Phillip Frost for Board Service Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Jan 15 Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Jan 15 Teva to Report Fourth Quarter 2014 Financial Results on February 5 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Jan 15 Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 15 Teva Launches Generic Diovan® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Dec 14 Teva Announces Launch of First Generic Celebrex® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Dec 14 Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Dec 14 Teva Announces Launch of Generic Exforge HCT® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 14 Teva to Report Third Quarter 2014 Financial Results on October 30 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
04 Sep 14 Teva Announces Launch of Generic Baraclude® Tablets 0.5mg and 1mg in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Sep 14 Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Aug 14 Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Jul 14 All Proposals Approved at Teva's Annual Meeting of Shareholders Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Jul 14 Teva to Report Second Quarter 2014 Financial Results on July 31, 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
16 Jul 14 Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting Proposals Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Jun 14 Teva Reaches Settlement in ProAir® HFA Patent Case Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Jun 14 Teva Reaches Settlements In NUVIGIL® Patent Case Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 14 Teva Announces U.S. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Jun 14 Teva to Present at the Goldman Sachs 35th Annual Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.